|
KMID : 1040420220260020097
|
|
Childhood Kidney Diseases
2022 Volume.26 No. 2 p.97 ~ p.100
|
|
|
Hypertensive crisis following mRNA COVID-19 vaccination in adolescents: two case reports
|
|
Cho Myung-Hyun
Cheong Hae-Il
|
|
|
Abstract
|
|
|
|
In response to the global coronavirus disease 2019 (COVID-19) pandemic, vaccines were developed and approved quickly. However, numerous cardiovascular adverse events have been reported. We present two adolescent cases who developed a hypertensive crisis following NT162b2 mRNA COVID-19 vaccination. Patient 1 was an 18-year-old male and his systolic blood pressure was 230 mmHg one day after the second vaccine. He was obese. No secondary cause of hypertension other than the vaccine was identified. Patient 2 was an 18-year-old male who complained with palpitation after the first vaccine. His blood pressure was 178/109 mmHg. He had autosomal dominant polycystic kidney disease. Both were treated with continuous infusion of labetalol followed by losartan, and blood pressure was controlled. Patient 2 received second vaccination and his blood pressure did not rise. It is warranted to measure blood pressure in adolescents at high risk of hypertension after NT162b2 mRNA COVID-19 vaccination.
|
|
|
KEYWORD
|
|
|
Adolescent, Blood pressure, COVID-19 vaccines, Hypertension, Messenger RNA
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
 
|